

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of protein localization to plasma membrane (GO:1903077) | 6.20879727 |
| 2 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 5.77596854 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.33481727 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.33481727 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.16364479 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.92078806 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.55443900 |
| 8 | signal peptide processing (GO:0006465) | 4.54487169 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.46002553 |
| 10 | negative regulation of cell killing (GO:0031342) | 4.46002553 |
| 11 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.07563382 |
| 12 | Golgi transport vesicle coating (GO:0048200) | 3.97600920 |
| 13 | COPI coating of Golgi vesicle (GO:0048205) | 3.97600920 |
| 14 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.93235564 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.85352327 |
| 16 | negative T cell selection (GO:0043383) | 3.80781208 |
| 17 | COPII vesicle coating (GO:0048208) | 3.73925416 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.71624869 |
| 19 | regulation of gamma-delta T cell activation (GO:0046643) | 3.70315312 |
| 20 | negative thymic T cell selection (GO:0045060) | 3.70061983 |
| 21 | regulation of metalloenzyme activity (GO:0048552) | 3.66339576 |
| 22 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.64311830 |
| 23 | response to interferon-beta (GO:0035456) | 3.58500105 |
| 24 | keratan sulfate catabolic process (GO:0042340) | 3.56906409 |
| 25 | nucleotide transmembrane transport (GO:1901679) | 3.49050310 |
| 26 | positive regulation of humoral immune response (GO:0002922) | 3.38145912 |
| 27 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.35249685 |
| 28 | positive regulation of isotype switching (GO:0045830) | 3.31832600 |
| 29 | definitive hemopoiesis (GO:0060216) | 3.31765080 |
| 30 | cellular response to interferon-beta (GO:0035458) | 3.29045391 |
| 31 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.28229823 |
| 32 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.27960056 |
| 33 | interferon-gamma production (GO:0032609) | 3.27831861 |
| 34 | regulation of protein localization to plasma membrane (GO:1903076) | 3.27657440 |
| 35 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.27562688 |
| 36 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.25369794 |
| 37 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.23739018 |
| 38 | iron ion import (GO:0097286) | 3.20931388 |
| 39 | transcytosis (GO:0045056) | 3.18199784 |
| 40 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.16956427 |
| 41 | negative regulation of complement activation (GO:0045916) | 3.16556723 |
| 42 | NIK/NF-kappaB signaling (GO:0038061) | 3.16405848 |
| 43 | response to type I interferon (GO:0034340) | 3.16209962 |
| 44 | desmosome organization (GO:0002934) | 3.15697646 |
| 45 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.14721178 |
| 46 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.14583196 |
| 47 | cellular response to type I interferon (GO:0071357) | 3.14168777 |
| 48 | type I interferon signaling pathway (GO:0060337) | 3.14168777 |
| 49 | T cell migration (GO:0072678) | 3.13919864 |
| 50 | regulation of protein polyubiquitination (GO:1902914) | 3.13172750 |
| 51 | regulation of RIG-I signaling pathway (GO:0039535) | 3.12228035 |
| 52 | type B pancreatic cell proliferation (GO:0044342) | 3.10819450 |
| 53 | daunorubicin metabolic process (GO:0044597) | 3.08571221 |
| 54 | polyketide metabolic process (GO:0030638) | 3.08571221 |
| 55 | doxorubicin metabolic process (GO:0044598) | 3.08571221 |
| 56 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.08273803 |
| 57 | cellular glucuronidation (GO:0052695) | 3.07821389 |
| 58 | negative regulation of protein activation cascade (GO:2000258) | 3.07502609 |
| 59 | response to interleukin-15 (GO:0070672) | 3.07098778 |
| 60 | negative regulation of humoral immune response (GO:0002921) | 3.05938890 |
| 61 | negative regulation of stress fiber assembly (GO:0051497) | 3.05454903 |
| 62 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.04782506 |
| 63 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.04738158 |
| 64 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.04062038 |
| 65 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.02880302 |
| 66 | neutrophil activation involved in immune response (GO:0002283) | 3.00924811 |
| 67 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.99935983 |
| 68 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.97722392 |
| 69 | positive regulation of DNA recombination (GO:0045911) | 2.95078151 |
| 70 | regulation of establishment of protein localization to plasma membrane (GO:0090003) | 2.94197903 |
| 71 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.93425950 |
| 72 | mast cell activation (GO:0045576) | 2.90723546 |
| 73 | cellular response to interleukin-15 (GO:0071350) | 2.89810737 |
| 74 | phenylpropanoid metabolic process (GO:0009698) | 2.88696058 |
| 75 | positive regulation of actin filament depolymerization (GO:0030836) | 2.87815197 |
| 76 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.86198363 |
| 77 | regulation of response to interferon-gamma (GO:0060330) | 2.85449803 |
| 78 | positive regulation of B cell mediated immunity (GO:0002714) | 2.83641222 |
| 79 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.83641222 |
| 80 | cell adhesion mediated by integrin (GO:0033627) | 2.81811409 |
| 81 | uronic acid metabolic process (GO:0006063) | 2.81752275 |
| 82 | glucuronate metabolic process (GO:0019585) | 2.81752275 |
| 83 | sphingomyelin metabolic process (GO:0006684) | 2.78240536 |
| 84 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.77703216 |
| 85 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.77519071 |
| 86 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.73632636 |
| 87 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.72632840 |
| 88 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.72527939 |
| 89 | necroptotic process (GO:0070266) | 2.72201228 |
| 90 | smooth muscle tissue development (GO:0048745) | 2.72122824 |
| 91 | organelle membrane fusion (GO:0090174) | 2.71641680 |
| 92 | autophagic vacuole fusion (GO:0000046) | 2.71390232 |
| 93 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.70913195 |
| 94 | response to protozoan (GO:0001562) | 2.69295828 |
| 95 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.68969931 |
| 96 | diterpenoid biosynthetic process (GO:0016102) | 2.68802844 |
| 97 | lipoprotein transport (GO:0042953) | 2.68702837 |
| 98 | defense response to protozoan (GO:0042832) | 2.67833313 |
| 99 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.67530320 |
| 100 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.66572744 |
| 101 | regulation of necroptotic process (GO:0060544) | 2.66016947 |
| 102 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.65114534 |
| 103 | regulation of isotype switching (GO:0045191) | 2.64218422 |
| 104 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.63965500 |
| 105 | amyloid precursor protein catabolic process (GO:0042987) | 2.61526510 |
| 106 | collagen fibril organization (GO:0030199) | 2.60761609 |
| 107 | magnesium ion transport (GO:0015693) | 2.60200138 |
| 108 | T cell selection (GO:0045058) | 2.59808393 |
| 109 | blood vessel maturation (GO:0001955) | 2.59060940 |
| 110 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.58438026 |
| 111 | positive thymic T cell selection (GO:0045059) | 2.58329067 |
| 112 | Golgi to endosome transport (GO:0006895) | 2.57872891 |
| 113 | hypotonic response (GO:0006971) | 2.57842329 |
| 114 | epoxygenase P450 pathway (GO:0019373) | 2.57592653 |
| 115 | virion attachment to host cell (GO:0019062) | 2.56470197 |
| 116 | adhesion of symbiont to host cell (GO:0044650) | 2.56470197 |
| 117 | peptide catabolic process (GO:0043171) | 2.56312871 |
| 118 | intestinal absorption (GO:0050892) | 2.55714937 |
| 119 | hyaluronan catabolic process (GO:0030214) | 2.55540896 |
| 120 | regulation of extracellular matrix disassembly (GO:0010715) | 2.54768945 |
| 121 | xenobiotic catabolic process (GO:0042178) | 2.54626953 |
| 122 | extracellular fibril organization (GO:0043206) | 2.53991133 |
| 123 | regulation of regulatory T cell differentiation (GO:0045589) | 2.52760806 |
| 124 | regulation of B cell differentiation (GO:0045577) | 2.52679015 |
| 125 | myeloid dendritic cell activation (GO:0001773) | 2.52227372 |
| 126 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.51623262 |
| 127 | thymic T cell selection (GO:0045061) | 2.51367655 |
| 128 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.50803077 |
| 129 | nucleotide-sugar metabolic process (GO:0009225) | 2.50626398 |
| 130 | pinocytosis (GO:0006907) | 2.50038347 |
| 131 | oligosaccharide biosynthetic process (GO:0009312) | 2.49185067 |
| 132 | oligosaccharide catabolic process (GO:0009313) | 2.47576197 |
| 133 | regulation of T cell tolerance induction (GO:0002664) | 2.47230172 |
| 134 | dendritic cell chemotaxis (GO:0002407) | 2.46897785 |
| 135 | dendritic cell migration (GO:0036336) | 2.46842316 |
| 136 | hepatocyte apoptotic process (GO:0097284) | 2.46400723 |
| 137 | primary alcohol catabolic process (GO:0034310) | 2.46099137 |
| 138 | T cell receptor signaling pathway (GO:0050852) | 2.45979127 |
| 139 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.44675407 |
| 140 | viral protein processing (GO:0019082) | 2.44598915 |
| 141 | parturition (GO:0007567) | 2.44230362 |
| 142 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.43763566 |
| 143 | regulation of B cell mediated immunity (GO:0002712) | 2.43758249 |
| 144 | positive regulation of B cell differentiation (GO:0045579) | 2.43583264 |
| 145 | actin filament depolymerization (GO:0030042) | 2.43290658 |
| 146 | actin nucleation (GO:0045010) | 2.43240577 |
| 147 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.43218685 |
| 148 | regulation of immunoglobulin mediated immune response (GO:0002889) | 2.41504511 |
| 149 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.41207762 |
| 150 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.40319452 |
| 151 | vesicle coating (GO:0006901) | 2.40043280 |
| 152 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.39783444 |
| 153 | membrane protein ectodomain proteolysis (GO:0006509) | 2.39766225 |
| 154 | ribosomal small subunit assembly (GO:0000028) | 2.39752874 |
| 155 | progesterone metabolic process (GO:0042448) | 2.39273158 |
| 156 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.39256934 |
| 157 | leukocyte aggregation (GO:0070486) | 2.38812751 |
| 158 | B cell receptor signaling pathway (GO:0050853) | 2.38724245 |
| 159 | regulation of interleukin-8 secretion (GO:2000482) | 2.38403050 |
| 160 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.37970822 |
| 161 | positive T cell selection (GO:0043368) | 2.37306093 |
| 162 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.37285609 |
| 163 | early endosome to late endosome transport (GO:0045022) | 2.36763036 |
| 164 | positive regulation of antigen processing and presentation (GO:0002579) | 2.35410168 |
| 165 | glycoside metabolic process (GO:0016137) | 2.35315118 |
| 166 | fibril organization (GO:0097435) | 2.34776235 |
| 167 | mast cell degranulation (GO:0043303) | 2.34611575 |
| 168 | mast cell activation involved in immune response (GO:0002279) | 2.34611575 |
| 169 | cyclooxygenase pathway (GO:0019371) | 2.34295743 |
| 170 | plasma lipoprotein particle assembly (GO:0034377) | 2.34139487 |
| 171 | regulation of intracellular pH (GO:0051453) | 2.33624066 |
| 172 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.33386290 |
| 173 | positive regulation of respiratory burst (GO:0060267) | 2.33203517 |
| 174 | retinal metabolic process (GO:0042574) | 2.32259797 |
| 175 | 4-hydroxyproline metabolic process (GO:0019471) | 2.30621417 |
| 176 | O-glycan processing (GO:0016266) | 2.30612246 |
| 177 | positive regulation of pseudopodium assembly (GO:0031274) | 2.28994928 |
| 178 | glutathione derivative biosynthetic process (GO:1901687) | 2.28685122 |
| 179 | glutathione derivative metabolic process (GO:1901685) | 2.28685122 |
| 180 | positive regulation of protein autophosphorylation (GO:0031954) | 2.28030412 |
| 181 | angiotensin maturation (GO:0002003) | 2.27777714 |
| 182 | regulation of receptor recycling (GO:0001919) | 2.25478635 |
| 183 | regulation of vitamin metabolic process (GO:0030656) | 2.20909734 |
| 184 | ethanol oxidation (GO:0006069) | 2.20644732 |
| 185 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.20035328 |
| 186 | retinol metabolic process (GO:0042572) | 2.19711124 |
| 187 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.19645834 |
| 188 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.18517091 |
| 189 | membrane protein proteolysis (GO:0033619) | 2.17996558 |
| 190 | cellular response to vitamin (GO:0071295) | 2.17933430 |
| 191 | protein-lipid complex assembly (GO:0065005) | 2.17510597 |
| 192 | protein localization to endosome (GO:0036010) | 2.16926741 |
| 193 | ethanol metabolic process (GO:0006067) | 2.16592812 |
| 194 | regulation of collagen metabolic process (GO:0010712) | 2.16232794 |
| 195 | skin morphogenesis (GO:0043589) | 2.16163933 |
| 196 | primary alcohol metabolic process (GO:0034308) | 2.15841085 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.90725522 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.70143066 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.02434282 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.35860632 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.32686820 |
| 6 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.17825665 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.09925430 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.08010042 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.99908143 |
| 10 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.95035759 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.90101538 |
| 12 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.85271051 |
| 13 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.80252938 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.79634807 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.50684860 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.50605481 |
| 17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39576047 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.37763989 |
| 19 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.33727972 |
| 20 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.31587408 |
| 21 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.29726116 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.22691430 |
| 23 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.14809358 |
| 24 | MYB_26560356_Chip-Seq_TH2_Human | 2.14212755 |
| 25 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.14079929 |
| 26 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.14079929 |
| 27 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.09856612 |
| 28 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.08965845 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.08867566 |
| 30 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.06894963 |
| 31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.06467213 |
| 32 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.05869861 |
| 33 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.04848842 |
| 34 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.03664179 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02151735 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98754308 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.97639493 |
| 38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94735221 |
| 39 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.93580554 |
| 40 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93226233 |
| 41 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.88918554 |
| 42 | CJUN_26792858_Chip-Seq_BT549_Human | 1.88871422 |
| 43 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.86912445 |
| 44 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85621532 |
| 45 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.85588649 |
| 46 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81935437 |
| 47 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.81272208 |
| 48 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.80125246 |
| 49 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.79215545 |
| 50 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.78759863 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78451359 |
| 52 | MYB_26560356_Chip-Seq_TH1_Human | 1.76673105 |
| 53 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.74813372 |
| 54 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.73226976 |
| 55 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71008510 |
| 56 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.70895340 |
| 57 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.70226024 |
| 58 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.68994756 |
| 59 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.67664316 |
| 60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.65064454 |
| 61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64401421 |
| 62 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.63791118 |
| 63 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.62673989 |
| 64 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.60950010 |
| 65 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.58586945 |
| 66 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.58488411 |
| 67 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58269900 |
| 68 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.58229901 |
| 69 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.56930946 |
| 70 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.55510564 |
| 71 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.55279243 |
| 72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.55216134 |
| 73 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.55150350 |
| 74 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.54829692 |
| 75 | MAF_26560356_Chip-Seq_TH1_Human | 1.54455598 |
| 76 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.54195276 |
| 77 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.53680823 |
| 78 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.53057475 |
| 79 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.52228549 |
| 80 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.49812419 |
| 81 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.49356016 |
| 82 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.48581299 |
| 83 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.47647969 |
| 84 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.47313686 |
| 85 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.46407215 |
| 86 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.46407215 |
| 87 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.45944887 |
| 88 | MYC_22102868_ChIP-Seq_BL_Human | 1.41484608 |
| 89 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41304172 |
| 90 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40565122 |
| 91 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.39877811 |
| 92 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.39391874 |
| 93 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.37703463 |
| 94 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36468425 |
| 95 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.36389403 |
| 96 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.32975771 |
| 97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31067786 |
| 98 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.30364992 |
| 99 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29903179 |
| 100 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.29070392 |
| 101 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28649151 |
| 102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.28580774 |
| 103 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.27552834 |
| 104 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.27036684 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26253587 |
| 106 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.25953310 |
| 107 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24970749 |
| 108 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.24413740 |
| 109 | UTX_26944678_Chip-Seq_JUKART_Human | 1.23837714 |
| 110 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.23738295 |
| 111 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.23169898 |
| 112 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.22954224 |
| 113 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.22474624 |
| 114 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22294344 |
| 115 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.21977230 |
| 116 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.21569739 |
| 117 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.21090859 |
| 118 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20884341 |
| 119 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20830277 |
| 120 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.19100856 |
| 121 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18886150 |
| 122 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.18837768 |
| 123 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17469190 |
| 124 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17067204 |
| 125 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.16679309 |
| 126 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16147174 |
| 127 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.15539835 |
| 128 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.14311343 |
| 129 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13987632 |
| 130 | GATA3_26560356_Chip-Seq_TH2_Human | 1.13919755 |
| 131 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13299851 |
| 132 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.12068614 |
| 133 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.11646363 |
| 134 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.11393903 |
| 135 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10585442 |
| 136 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10354565 |
| 137 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.10210128 |
| 138 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.09568517 |
| 139 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.09547647 |
| 140 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.08841482 |
| 141 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08081597 |
| 142 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.08048114 |
| 143 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08037638 |
| 144 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.07412154 |
| 145 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07307698 |
| 146 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06448481 |
| 147 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06037692 |
| 148 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.05979610 |
| 149 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04971292 |
| 150 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.04713310 |
| 151 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04497002 |
| 152 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04003870 |
| 153 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.03637656 |
| 154 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.03332326 |
| 155 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02566056 |
| 156 | MAF_26560356_Chip-Seq_TH2_Human | 1.02440534 |
| 157 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.02315915 |
| 158 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02229973 |
| 159 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.01993423 |
| 160 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01317496 |
| 161 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.01248322 |
| 162 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01143203 |
| 163 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00809323 |
| 164 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.00668468 |
| 165 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.00596169 |
| 166 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00411983 |
| 167 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.99618375 |
| 168 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99197647 |
| 169 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.99168421 |
| 170 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98414861 |
| 171 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98353524 |
| 172 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98005076 |
| 173 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.97754002 |
| 174 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.97642035 |
| 175 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96566347 |
| 176 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.94578872 |
| 177 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.93828053 |
| 178 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.88543090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.21856398 |
| 2 | MP0003724_increased_susceptibility_to | 3.85837706 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.24708103 |
| 4 | MP0000685_abnormal_immune_system | 3.24355350 |
| 5 | MP0003763_abnormal_thymus_physiology | 3.08211979 |
| 6 | MP0005671_abnormal_response_to | 2.94634297 |
| 7 | MP0009785_altered_susceptibility_to | 2.80171281 |
| 8 | MP0005275_abnormal_skin_tensile | 2.79206651 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.58179712 |
| 10 | MP0003436_decreased_susceptibility_to | 2.57987198 |
| 11 | MP0004272_abnormal_basement_membrane | 2.52218816 |
| 12 | MP0001800_abnormal_humoral_immune | 2.46760893 |
| 13 | MP0003950_abnormal_plasma_membrane | 2.46708275 |
| 14 | MP0005387_immune_system_phenotype | 2.42779479 |
| 15 | MP0001790_abnormal_immune_system | 2.42779479 |
| 16 | MP0003866_abnormal_defecation | 2.36545675 |
| 17 | MP0002396_abnormal_hematopoietic_system | 2.34314086 |
| 18 | MP0003279_aneurysm | 2.33288489 |
| 19 | MP0001873_stomach_inflammation | 2.32899618 |
| 20 | MP0002723_abnormal_immune_serum | 2.31681377 |
| 21 | MP0003941_abnormal_skin_development | 2.30493770 |
| 22 | MP0006082_CNS_inflammation | 2.26684477 |
| 23 | MP0005058_abnormal_lysosome_morphology | 2.22257970 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.19967064 |
| 25 | MP0005025_abnormal_response_to | 2.19564840 |
| 26 | MP0001819_abnormal_immune_cell | 2.17936140 |
| 27 | MP0002452_abnormal_antigen_presenting | 2.17270413 |
| 28 | MP0005503_abnormal_tendon_morphology | 2.16303556 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 2.14568046 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 2.09701614 |
| 31 | MP0005257_abnormal_intraocular_pressure | 2.07861881 |
| 32 | MP0002398_abnormal_bone_marrow | 2.06636796 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.98814413 |
| 34 | MP0002419_abnormal_innate_immunity | 1.96473167 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.96240578 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.96124174 |
| 37 | MP0002102_abnormal_ear_morphology | 1.95076937 |
| 38 | MP0010234_abnormal_vibrissa_follicle | 1.90910724 |
| 39 | MP0000716_abnormal_immune_system | 1.88036742 |
| 40 | MP0002139_abnormal_hepatobiliary_system | 1.84521858 |
| 41 | MP0001542_abnormal_bone_strength | 1.84444080 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.76297725 |
| 43 | MP0000689_abnormal_spleen_morphology | 1.75433128 |
| 44 | MP0002405_respiratory_system_inflammati | 1.74796932 |
| 45 | MP0005464_abnormal_platelet_physiology | 1.74347382 |
| 46 | MP0005075_abnormal_melanosome_morpholog | 1.71023163 |
| 47 | MP0001958_emphysema | 1.70864779 |
| 48 | MP0006054_spinal_hemorrhage | 1.68887935 |
| 49 | MP0009384_cardiac_valve_regurgitation | 1.67142496 |
| 50 | MP0002722_abnormal_immune_system | 1.66751936 |
| 51 | MP0001845_abnormal_inflammatory_respons | 1.66342488 |
| 52 | MP0002429_abnormal_blood_cell | 1.65325254 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 1.61783904 |
| 54 | MP0002933_joint_inflammation | 1.55055825 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.50146876 |
| 56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.49339297 |
| 57 | MP0008469_abnormal_protein_level | 1.48212704 |
| 58 | MP0005365_abnormal_bile_salt | 1.46779694 |
| 59 | MP0003943_abnormal_hepatobiliary_system | 1.46072700 |
| 60 | MP0004947_skin_inflammation | 1.43002449 |
| 61 | MP0005165_increased_susceptibility_to | 1.42451125 |
| 62 | MP0000371_diluted_coat_color | 1.42340665 |
| 63 | MP0005310_abnormal_salivary_gland | 1.42195499 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 1.41874608 |
| 65 | MP0001533_abnormal_skeleton_physiology | 1.40850834 |
| 66 | MP0002006_tumorigenesis | 1.39936626 |
| 67 | MP0008260_abnormal_autophagy | 1.39406842 |
| 68 | MP0000703_abnormal_thymus_morphology | 1.39003798 |
| 69 | MP0000490_abnormal_crypts_of | 1.38406000 |
| 70 | MP0003806_abnormal_nucleotide_metabolis | 1.37201246 |
| 71 | MP0002060_abnormal_skin_morphology | 1.35474447 |
| 72 | MP0005023_abnormal_wound_healing | 1.32393885 |
| 73 | MP0010368_abnormal_lymphatic_system | 1.30724921 |
| 74 | MP0000013_abnormal_adipose_tissue | 1.28333851 |
| 75 | MP0003656_abnormal_erythrocyte_physiolo | 1.26087572 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 1.25232683 |
| 77 | MP0005332_abnormal_amino_acid | 1.24879148 |
| 78 | MP0004147_increased_porphyrin_level | 1.24572671 |
| 79 | MP0009780_abnormal_chondrocyte_physiolo | 1.22847794 |
| 80 | MP0003300_gastrointestinal_ulcer | 1.22668039 |
| 81 | MP0002295_abnormal_pulmonary_circulatio | 1.21069896 |
| 82 | MP0003186_abnormal_redox_activity | 1.16328749 |
| 83 | MP0005164_abnormal_response_to | 1.15508228 |
| 84 | MP0000858_altered_metastatic_potential | 1.15477024 |
| 85 | MP0005360_urolithiasis | 1.14723052 |
| 86 | MP0004019_abnormal_vitamin_homeostasis | 1.12898556 |
| 87 | MP0000767_abnormal_smooth_muscle | 1.12228722 |
| 88 | MP0004484_altered_response_of | 1.11544083 |
| 89 | MP0010386_abnormal_urinary_bladder | 1.10617754 |
| 90 | MP0001545_abnormal_hematopoietic_system | 1.09955035 |
| 91 | MP0005397_hematopoietic_system_phenotyp | 1.09955035 |
| 92 | MP0000462_abnormal_digestive_system | 1.09649913 |
| 93 | MP0005174_abnormal_tail_pigmentation | 1.07230920 |
| 94 | MP0003091_abnormal_cell_migration | 1.06353105 |
| 95 | MP0002896_abnormal_bone_mineralization | 1.06181180 |
| 96 | MP0001853_heart_inflammation | 1.05725250 |
| 97 | MP0003183_abnormal_peptide_metabolism | 1.00555550 |
| 98 | MP0001243_abnormal_dermal_layer | 1.00298303 |
| 99 | MP0003566_abnormal_cell_adhesion | 0.99930556 |
| 100 | MP0009764_decreased_sensitivity_to | 0.99399430 |
| 101 | MP0002693_abnormal_pancreas_physiology | 0.98283986 |
| 102 | MP0010094_abnormal_chromosome_stability | 0.96149560 |
| 103 | MP0005220_abnormal_exocrine_pancreas | 0.96140387 |
| 104 | MP0009840_abnormal_foam_cell | 0.94038638 |
| 105 | MP0003172_abnormal_lysosome_physiology | 0.93958483 |
| 106 | MP0001666_abnormal_nutrient_absorption | 0.93901370 |
| 107 | MP0001756_abnormal_urination | 0.93606303 |
| 108 | MP0008007_abnormal_cellular_replicative | 0.93269055 |
| 109 | MP0009763_increased_sensitivity_to | 0.92419073 |
| 110 | MP0009643_abnormal_urine_homeostasis | 0.91288768 |
| 111 | MP0010329_abnormal_lipoprotein_level | 0.90893504 |
| 112 | MP0002168_other_aberrant_phenotype | 0.90420955 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.89767719 |
| 114 | MP0005367_renal/urinary_system_phenotyp | 0.88716630 |
| 115 | MP0000516_abnormal_urinary_system | 0.88716630 |
| 116 | MP0000609_abnormal_liver_physiology | 0.88588126 |
| 117 | MP0009697_abnormal_copulation | 0.87853422 |
| 118 | MP0000343_altered_response_to | 0.87656271 |
| 119 | MP0002019_abnormal_tumor_incidence | 0.87137954 |
| 120 | MP0003705_abnormal_hypodermis_morpholog | 0.86912294 |
| 121 | MP0005085_abnormal_gallbladder_physiolo | 0.86485080 |
| 122 | MP0008004_abnormal_stomach_pH | 0.86435324 |
| 123 | MP0000372_irregular_coat_pigmentation | 0.85953123 |
| 124 | MP0004043_abnormal_pH_regulation | 0.85869066 |
| 125 | MP0005083_abnormal_biliary_tract | 0.83787147 |
| 126 | MP0005451_abnormal_body_composition | 0.83592798 |
| 127 | MP0000015_abnormal_ear_pigmentation | 0.82928702 |
| 128 | MP0003252_abnormal_bile_duct | 0.82341284 |
| 129 | MP0005508_abnormal_skeleton_morphology | 0.81923891 |
| 130 | MP0002132_abnormal_respiratory_system | 0.81745877 |
| 131 | MP0005623_abnormal_meninges_morphology | 0.81074838 |
| 132 | MP0000598_abnormal_liver_morphology | 0.79264456 |
| 133 | MP0001764_abnormal_homeostasis | 0.78680723 |
| 134 | MP0005171_absent_coat_pigmentation | 0.78679825 |
| 135 | MP0003303_peritoneal_inflammation | 0.77577884 |
| 136 | MP0004134_abnormal_chest_morphology | 0.77537301 |
| 137 | MP0004883_abnormal_blood_vessel | 0.76582351 |
| 138 | MP0003868_abnormal_feces_composition | 0.75427815 |
| 139 | MP0001879_abnormal_lymphatic_vessel | 0.75234361 |
| 140 | MP0009379_abnormal_foot_pigmentation | 0.75166458 |
| 141 | MP0000358_abnormal_cell_content/ | 0.74779459 |
| 142 | MP0008873_increased_physiological_sensi | 0.74222921 |
| 143 | MP0005636_abnormal_mineral_homeostasis | 0.74095417 |
| 144 | MP0002928_abnormal_bile_duct | 0.73543390 |
| 145 | MP0000569_abnormal_digit_pigmentation | 0.73334129 |
| 146 | MP0001663_abnormal_digestive_system | 0.72722097 |
| 147 | MP0003693_abnormal_embryo_hatching | 0.72269678 |
| 148 | MP0005319_abnormal_enzyme/_coenzyme | 0.72187776 |
| 149 | MP0002136_abnormal_kidney_physiology | 0.70467658 |
| 150 | MP0006035_abnormal_mitochondrial_morpho | 0.70422373 |
| 151 | MP0003195_calcinosis | 0.70316313 |
| 152 | MP0005408_hypopigmentation | 0.70183437 |
| 153 | MP0001348_abnormal_lacrimal_gland | 0.70142589 |
| 154 | MP0001661_extended_life_span | 0.70084527 |
| 155 | MP0005390_skeleton_phenotype | 0.69817422 |
| 156 | MP0003795_abnormal_bone_structure | 0.69687605 |
| 157 | MP0002998_abnormal_bone_remodeling | 0.68952694 |
| 158 | MP0002877_abnormal_melanocyte_morpholog | 0.67551243 |
| 159 | MP0003828_pulmonary_edema | 0.65519086 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Premature rupture of membranes (HP:0001788) | 4.70722322 |
| 2 | Abnormality of T cell number (HP:0011839) | 3.98516531 |
| 3 | T lymphocytopenia (HP:0005403) | 3.80514765 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.75767228 |
| 5 | Myositis (HP:0100614) | 3.74342008 |
| 6 | Tetraparesis (HP:0002273) | 3.71880503 |
| 7 | Thrombocytosis (HP:0001894) | 3.69981421 |
| 8 | Cervical subluxation (HP:0003308) | 3.69670288 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 3.60061026 |
| 10 | Autoimmune thrombocytopenia (HP:0001973) | 3.58264670 |
| 11 | Autoimmune hemolytic anemia (HP:0001890) | 3.56017199 |
| 12 | IgM deficiency (HP:0002850) | 3.47786039 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.47465039 |
| 14 | Follicular hyperkeratosis (HP:0007502) | 3.43912962 |
| 15 | Abnormality of T cells (HP:0002843) | 3.41816458 |
| 16 | Generalized aminoaciduria (HP:0002909) | 3.30152998 |
| 17 | Mucopolysacchariduria (HP:0008155) | 3.29078370 |
| 18 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.29078370 |
| 19 | Aortic dissection (HP:0002647) | 3.29036179 |
| 20 | Cardiovascular calcification (HP:0011915) | 3.21727302 |
| 21 | Orchitis (HP:0100796) | 3.20796644 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.20759336 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.20759336 |
| 24 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.20759336 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 3.18546281 |
| 26 | Optic neuritis (HP:0100653) | 3.18546281 |
| 27 | Chronic otitis media (HP:0000389) | 3.18103019 |
| 28 | Protrusio acetabuli (HP:0003179) | 3.17431356 |
| 29 | Increased IgM level (HP:0003496) | 3.14732202 |
| 30 | Peritonitis (HP:0002586) | 3.08739703 |
| 31 | Petechiae (HP:0000967) | 3.06428130 |
| 32 | Recurrent viral infections (HP:0004429) | 3.05283608 |
| 33 | Type I transferrin isoform profile (HP:0003642) | 3.04901980 |
| 34 | Recurrent bronchitis (HP:0002837) | 3.04725510 |
| 35 | Abnormality of T cell physiology (HP:0011840) | 2.99281645 |
| 36 | Severe combined immunodeficiency (HP:0004430) | 2.95453177 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.92510896 |
| 38 | Recurrent fungal infections (HP:0002841) | 2.83118891 |
| 39 | Hyperlipoproteinemia (HP:0010980) | 2.82631355 |
| 40 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.81440012 |
| 41 | Mitral stenosis (HP:0001718) | 2.81009962 |
| 42 | Hydroxyprolinuria (HP:0003080) | 2.80288729 |
| 43 | Abnormality of proline metabolism (HP:0010907) | 2.80288729 |
| 44 | Abnormality of B cell number (HP:0010975) | 2.80211387 |
| 45 | B lymphocytopenia (HP:0010976) | 2.80211387 |
| 46 | Combined immunodeficiency (HP:0005387) | 2.79286411 |
| 47 | Chronic diarrhea (HP:0002028) | 2.79022300 |
| 48 | Ovoid vertebral bodies (HP:0003300) | 2.78953907 |
| 49 | Recurrent abscess formation (HP:0002722) | 2.78600160 |
| 50 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.78493222 |
| 51 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.75369181 |
| 52 | Vascular tortuosity (HP:0004948) | 2.73742211 |
| 53 | Vascular calcification (HP:0004934) | 2.73161746 |
| 54 | Epistaxis (HP:0000421) | 2.70828306 |
| 55 | Vasculitis (HP:0002633) | 2.70633235 |
| 56 | Nonimmune hydrops fetalis (HP:0001790) | 2.70007218 |
| 57 | Abnormality of eosinophils (HP:0001879) | 2.69750537 |
| 58 | Metaphyseal dysplasia (HP:0100255) | 2.69663104 |
| 59 | Eczematoid dermatitis (HP:0000976) | 2.68840788 |
| 60 | IgG deficiency (HP:0004315) | 2.68812145 |
| 61 | Eosinophilia (HP:0001880) | 2.63732337 |
| 62 | Joint swelling (HP:0001386) | 2.62136680 |
| 63 | Leukocytosis (HP:0001974) | 2.58275780 |
| 64 | Albinism (HP:0001022) | 2.57698495 |
| 65 | Recurrent bacterial skin infections (HP:0005406) | 2.56842719 |
| 66 | Intrahepatic cholestasis (HP:0001406) | 2.55965419 |
| 67 | Abnormal glycosylation (HP:0012345) | 2.52848548 |
| 68 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.52848548 |
| 69 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.52848548 |
| 70 | Abnormal protein glycosylation (HP:0012346) | 2.52848548 |
| 71 | Hypoplasia of the thymus (HP:0000778) | 2.52801221 |
| 72 | Granulocytopenia (HP:0001913) | 2.52361048 |
| 73 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.52101449 |
| 74 | Hand muscle atrophy (HP:0009130) | 2.51994057 |
| 75 | Reduced antithrombin III activity (HP:0001976) | 2.51646194 |
| 76 | Thyroiditis (HP:0100646) | 2.50958775 |
| 77 | Atrophic scars (HP:0001075) | 2.50287077 |
| 78 | Symptomatic seizures (HP:0011145) | 2.48490459 |
| 79 | Fat malabsorption (HP:0002630) | 2.46527274 |
| 80 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.42720582 |
| 81 | Arterial tortuosity (HP:0005116) | 2.40597478 |
| 82 | Keratoconjunctivitis sicca (HP:0001097) | 2.38872498 |
| 83 | Gingival bleeding (HP:0000225) | 2.38742279 |
| 84 | Panhypogammaglobulinemia (HP:0003139) | 2.38507315 |
| 85 | Aortic aneurysm (HP:0004942) | 2.36668317 |
| 86 | Soft skin (HP:0000977) | 2.36075760 |
| 87 | Encephalitis (HP:0002383) | 2.31220491 |
| 88 | Dilatation of the ascending aorta (HP:0005111) | 2.31071503 |
| 89 | 3-Methylglutaconic aciduria (HP:0003535) | 2.30629817 |
| 90 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.29367172 |
| 91 | Abnormality of macrophages (HP:0004311) | 2.28379331 |
| 92 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.28116196 |
| 93 | Lymphoma (HP:0002665) | 2.27079843 |
| 94 | Arterial thrombosis (HP:0004420) | 2.25947954 |
| 95 | Patchy hypopigmentation of hair (HP:0011365) | 2.24983271 |
| 96 | Lymphopenia (HP:0001888) | 2.24664471 |
| 97 | Impaired platelet aggregation (HP:0003540) | 2.22998824 |
| 98 | Abnormal platelet function (HP:0011869) | 2.22998824 |
| 99 | Glucose intolerance (HP:0000833) | 2.22640014 |
| 100 | Orthostatic hypotension (HP:0001278) | 2.21902890 |
| 101 | Prolonged bleeding time (HP:0003010) | 2.21725903 |
| 102 | Prolonged partial thromboplastin time (HP:0003645) | 2.20719825 |
| 103 | Entropion (HP:0000621) | 2.19101276 |
| 104 | IgA deficiency (HP:0002720) | 2.18194359 |
| 105 | Meningitis (HP:0001287) | 2.16811464 |
| 106 | Steatorrhea (HP:0002570) | 2.16696229 |
| 107 | Abnormality of dentin (HP:0010299) | 2.14847052 |
| 108 | Neutropenia (HP:0001875) | 2.14566392 |
| 109 | Hyperalaninemia (HP:0003348) | 2.14507996 |
| 110 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.14507996 |
| 111 | Abnormality of alanine metabolism (HP:0010916) | 2.14507996 |
| 112 | Keratoconjunctivitis (HP:0001096) | 2.13366441 |
| 113 | Amaurosis fugax (HP:0100576) | 2.13356724 |
| 114 | Right ventricular cardiomyopathy (HP:0011663) | 2.11602717 |
| 115 | Spondylolisthesis (HP:0003302) | 2.10720827 |
| 116 | Dysostosis multiplex (HP:0000943) | 2.10130348 |
| 117 | Recurrent skin infections (HP:0001581) | 2.08838112 |
| 118 | Abnormality of the prostate (HP:0008775) | 2.08011506 |
| 119 | Aplastic anemia (HP:0001915) | 2.05607485 |
| 120 | Hypergammaglobulinemia (HP:0010702) | 2.05053316 |
| 121 | Beaking of vertebral bodies (HP:0004568) | 2.04532562 |
| 122 | Nasal polyposis (HP:0100582) | 2.02038370 |
| 123 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.01835874 |
| 124 | Gastrointestinal stroma tumor (HP:0100723) | 2.01537998 |
| 125 | Hypothermia (HP:0002045) | 2.01273415 |
| 126 | Abnormality of glycolipid metabolism (HP:0010969) | 2.01247620 |
| 127 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.01247620 |
| 128 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.01247620 |
| 129 | Blue sclerae (HP:0000592) | 2.00621079 |
| 130 | Upper limb amyotrophy (HP:0009129) | 1.99239967 |
| 131 | Distal upper limb amyotrophy (HP:0007149) | 1.99239967 |
| 132 | Pustule (HP:0200039) | 1.97852223 |
| 133 | Cutaneous melanoma (HP:0012056) | 1.97569213 |
| 134 | Pulmonary infiltrates (HP:0002113) | 1.97109884 |
| 135 | Increased CSF protein (HP:0002922) | 1.96566912 |
| 136 | Bronchitis (HP:0012387) | 1.96236577 |
| 137 | Mediastinal lymphadenopathy (HP:0100721) | 1.95006789 |
| 138 | Xanthomatosis (HP:0000991) | 1.92694947 |
| 139 | Osteolytic defects of the hand bones (HP:0009699) | 1.91616269 |
| 140 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.91616269 |
| 141 | Microretrognathia (HP:0000308) | 1.91540237 |
| 142 | Recurrent cutaneous fungal infections (HP:0011370) | 1.91522579 |
| 143 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.91522579 |
| 144 | Large eyes (HP:0001090) | 1.90869773 |
| 145 | Myocardial infarction (HP:0001658) | 1.90133787 |
| 146 | 11 pairs of ribs (HP:0000878) | 1.89039418 |
| 147 | Tongue fasciculations (HP:0001308) | 1.88684279 |
| 148 | Posterior subcapsular cataract (HP:0007787) | 1.88376749 |
| 149 | Spontaneous hematomas (HP:0007420) | 1.88341793 |
| 150 | Joint hemorrhage (HP:0005261) | 1.88304214 |
| 151 | Aortic valve stenosis (HP:0001650) | 1.88118308 |
| 152 | Chondrocalcinosis (HP:0000934) | 1.86777157 |
| 153 | Fatigue (HP:0012378) | 1.86118806 |
| 154 | Nausea (HP:0002018) | 1.85716325 |
| 155 | Hemoptysis (HP:0002105) | 1.85357002 |
| 156 | Periodontitis (HP:0000704) | 1.84990428 |
| 157 | Broad face (HP:0000283) | 1.83845846 |
| 158 | Abnormality of the nasal mucosa (HP:0000433) | 1.83757389 |
| 159 | Increased corneal curvature (HP:0100692) | 1.83536181 |
| 160 | Keratoconus (HP:0000563) | 1.83536181 |
| 161 | Abnormality of vitamin B metabolism (HP:0004340) | 1.81900668 |
| 162 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.81156892 |
| 163 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.80547653 |
| 164 | Abnormal glucose tolerance (HP:0001952) | 1.80191798 |
| 165 | Recurrent pneumonia (HP:0006532) | 1.80041126 |
| 166 | Hyperactive renin-angiotensin system (HP:0000841) | 1.79697975 |
| 167 | Abnormality of the intrinsic pathway (HP:0010989) | 1.79587208 |
| 168 | Wormian bones (HP:0002645) | 1.79377507 |
| 169 | Neoplasm of head and neck (HP:0012288) | 1.78769675 |
| 170 | White forelock (HP:0002211) | 1.78479256 |
| 171 | Hematochezia (HP:0002573) | 1.78162609 |
| 172 | Upper motor neuron abnormality (HP:0002127) | 1.76542246 |
| 173 | Alopecia of scalp (HP:0002293) | 1.76196789 |
| 174 | Abnormality of vitamin metabolism (HP:0100508) | 1.75305094 |
| 175 | Abnormality of Sharpey fibers (HP:0100685) | 1.75304569 |
| 176 | Abnormality of carpal bone ossification (HP:0006257) | 1.74945220 |
| 177 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.73937227 |
| 178 | Abnormality of the acetabulum (HP:0003170) | 1.73818993 |
| 179 | Syringomyelia (HP:0003396) | 1.69705786 |
| 180 | Spinal cord lesions (HP:0100561) | 1.69705786 |
| 181 | Fragile skin (HP:0001030) | 1.69332480 |
| 182 | Ankle contracture (HP:0006466) | 1.68563424 |
| 183 | Loss of speech (HP:0002371) | 1.68190427 |
| 184 | Muscle fibrillation (HP:0010546) | 1.68162561 |
| 185 | Delayed gross motor development (HP:0002194) | 1.68151193 |
| 186 | Dry hair (HP:0011359) | 1.68106352 |
| 187 | Hypoalphalipoproteinemia (HP:0003233) | 1.66007970 |
| 188 | Vertebral compression fractures (HP:0002953) | 1.65997948 |
| 189 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.65906776 |
| 190 | Villous atrophy (HP:0011473) | 1.65906776 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MUSK | 3.83440750 |
| 2 | TIE1 | 3.82773224 |
| 3 | MAP4K1 | 3.45283249 |
| 4 | TXK | 3.41780868 |
| 5 | TEC | 3.10946491 |
| 6 | MAP3K14 | 3.00432175 |
| 7 | MYLK | 2.65934192 |
| 8 | STK39 | 2.63751308 |
| 9 | ACVR1B | 2.49340375 |
| 10 | IRAK4 | 2.49211177 |
| 11 | TAOK3 | 2.45261916 |
| 12 | ERBB3 | 2.44474167 |
| 13 | ZAP70 | 2.44458255 |
| 14 | ADRBK2 | 2.36528515 |
| 15 | LATS1 | 2.33747729 |
| 16 | BLK | 2.30784747 |
| 17 | JAK3 | 2.28102385 |
| 18 | ITK | 2.22095793 |
| 19 | TBK1 | 2.21108313 |
| 20 | DDR2 | 2.19087649 |
| 21 | INSRR | 2.17107697 |
| 22 | PDK2 | 2.08966359 |
| 23 | FLT3 | 2.00611592 |
| 24 | IKBKE | 1.99190416 |
| 25 | KIT | 1.95230564 |
| 26 | TYK2 | 1.95165442 |
| 27 | MAP3K4 | 1.86785275 |
| 28 | MAP3K2 | 1.85223659 |
| 29 | MAPKAPK3 | 1.85045886 |
| 30 | BTK | 1.78337422 |
| 31 | MAP3K3 | 1.71278547 |
| 32 | TRIM28 | 1.70935304 |
| 33 | STK10 | 1.65616020 |
| 34 | ERN1 | 1.64250238 |
| 35 | PIM2 | 1.58977570 |
| 36 | JAK1 | 1.48837628 |
| 37 | IKBKB | 1.48825516 |
| 38 | LIMK1 | 1.46505749 |
| 39 | FER | 1.46315372 |
| 40 | PIK3CG | 1.46198699 |
| 41 | STK3 | 1.43020828 |
| 42 | EIF2AK3 | 1.42408957 |
| 43 | BMPR1B | 1.41724455 |
| 44 | PDGFRA | 1.40234140 |
| 45 | MST1R | 1.39421211 |
| 46 | BMPR2 | 1.38675618 |
| 47 | TGFBR1 | 1.37191542 |
| 48 | NME2 | 1.36890257 |
| 49 | BRSK2 | 1.33894224 |
| 50 | PAK4 | 1.33314867 |
| 51 | MAP3K13 | 1.32325701 |
| 52 | MET | 1.28911907 |
| 53 | OXSR1 | 1.24331673 |
| 54 | KDR | 1.24317037 |
| 55 | SYK | 1.22875033 |
| 56 | SCYL2 | 1.21861854 |
| 57 | FGFR4 | 1.21616021 |
| 58 | LCK | 1.19264933 |
| 59 | BCR | 1.17245725 |
| 60 | PBK | 1.17188080 |
| 61 | GRK7 | 1.15207058 |
| 62 | CSK | 1.12381866 |
| 63 | CSF1R | 1.11471688 |
| 64 | NLK | 1.09635856 |
| 65 | GRK6 | 1.08726363 |
| 66 | AKT3 | 1.07612416 |
| 67 | TGFBR2 | 1.06547526 |
| 68 | EPHA2 | 1.06160224 |
| 69 | NUAK1 | 1.05548708 |
| 70 | WNK3 | 1.04700885 |
| 71 | PTK2B | 1.03160184 |
| 72 | LMTK2 | 1.01238976 |
| 73 | IRAK3 | 1.00707979 |
| 74 | LYN | 0.99785085 |
| 75 | PASK | 0.95008651 |
| 76 | ABL2 | 0.93073480 |
| 77 | TRPM7 | 0.91763834 |
| 78 | PRKCQ | 0.89887124 |
| 79 | PLK2 | 0.87578635 |
| 80 | PTK2 | 0.85511889 |
| 81 | PIM1 | 0.84116191 |
| 82 | CHUK | 0.82083390 |
| 83 | STK16 | 0.82030356 |
| 84 | PRKCE | 0.81760283 |
| 85 | EIF2AK1 | 0.81410148 |
| 86 | LRRK2 | 0.80949027 |
| 87 | RPS6KA4 | 0.80540201 |
| 88 | VRK1 | 0.79674328 |
| 89 | PLK4 | 0.77992450 |
| 90 | CLK1 | 0.76241934 |
| 91 | ERBB4 | 0.76151653 |
| 92 | MAP2K7 | 0.73552668 |
| 93 | CASK | 0.72496618 |
| 94 | PRKG2 | 0.71735233 |
| 95 | TESK2 | 0.69263249 |
| 96 | ADRBK1 | 0.68368603 |
| 97 | CDK6 | 0.67335334 |
| 98 | FRK | 0.66947889 |
| 99 | PINK1 | 0.65656106 |
| 100 | ABL1 | 0.64523816 |
| 101 | ILK | 0.63298188 |
| 102 | WNK4 | 0.62658627 |
| 103 | HCK | 0.61774750 |
| 104 | STK38L | 0.61380709 |
| 105 | NEK1 | 0.59565735 |
| 106 | BUB1 | 0.58101237 |
| 107 | MAP3K12 | 0.55169459 |
| 108 | MATK | 0.54318123 |
| 109 | CAMKK2 | 0.53640783 |
| 110 | MST4 | 0.53221562 |
| 111 | STK24 | 0.52803772 |
| 112 | SIK3 | 0.50510029 |
| 113 | MAP3K5 | 0.49883776 |
| 114 | RIPK4 | 0.48923333 |
| 115 | MAPKAPK2 | 0.48337817 |
| 116 | IRAK1 | 0.46537461 |
| 117 | MAP2K2 | 0.46413996 |
| 118 | PAK2 | 0.46379275 |
| 119 | MELK | 0.45066700 |
| 120 | MAP3K7 | 0.44634376 |
| 121 | TSSK6 | 0.44326805 |
| 122 | MAP3K6 | 0.43089451 |
| 123 | PAK3 | 0.41110469 |
| 124 | GRK1 | 0.40953978 |
| 125 | MAPK11 | 0.40505443 |
| 126 | FGFR3 | 0.38932482 |
| 127 | MOS | 0.38736344 |
| 128 | BCKDK | 0.35994039 |
| 129 | IGF1R | 0.35270229 |
| 130 | JAK2 | 0.34287981 |
| 131 | YES1 | 0.33813708 |
| 132 | RPS6KA6 | 0.33425945 |
| 133 | MARK3 | 0.33343741 |
| 134 | TESK1 | 0.32604860 |
| 135 | PTK6 | 0.32508771 |
| 136 | PRKCD | 0.32371326 |
| 137 | PDGFRB | 0.31984792 |
| 138 | CCNB1 | 0.31827607 |
| 139 | MAPK3 | 0.31814828 |
| 140 | CDK8 | 0.30647354 |
| 141 | PRKD1 | 0.28719559 |
| 142 | NEK9 | 0.27811258 |
| 143 | EPHA3 | 0.27176964 |
| 144 | ROCK2 | 0.26942503 |
| 145 | MAP3K10 | 0.25774099 |
| 146 | PIK3CA | 0.25089242 |
| 147 | GSK3A | 0.24580396 |
| 148 | IRAK2 | 0.24109351 |
| 149 | RPS6KC1 | 0.23821491 |
| 150 | RPS6KL1 | 0.23821491 |
| 151 | ATR | 0.23667024 |
| 152 | EIF2AK2 | 0.23267820 |
| 153 | FES | 0.23130322 |
| 154 | DYRK3 | 0.21381431 |
| 155 | CSNK1G3 | 0.20951923 |
| 156 | MAP2K3 | 0.20503918 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.25561662 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.00972243 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.65507319 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.60698099 |
| 5 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.37767575 |
| 6 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.36380957 |
| 7 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.26118956 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.18210123 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.15471983 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.13122445 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.11478790 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.08187037 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.03844382 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.00144240 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.99299538 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.97763457 |
| 17 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.96349944 |
| 18 | Leishmaniasis_Homo sapiens_hsa05140 | 1.87790722 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.86681369 |
| 20 | Retinol metabolism_Homo sapiens_hsa00830 | 1.77203141 |
| 21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.72493172 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.65671299 |
| 23 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.63848479 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.63714168 |
| 25 | Other glycan degradation_Homo sapiens_hsa00511 | 1.62572678 |
| 26 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.62344493 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.61704215 |
| 28 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.58632969 |
| 29 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.56030455 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.55328398 |
| 31 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.52729723 |
| 32 | DNA replication_Homo sapiens_hsa03030 | 1.50314850 |
| 33 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.47711451 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.47558184 |
| 35 | Ribosome_Homo sapiens_hsa03010 | 1.46282792 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.43703257 |
| 37 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.41772862 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36717936 |
| 39 | Legionellosis_Homo sapiens_hsa05134 | 1.36431250 |
| 40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33715465 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.31987613 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.31937177 |
| 43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.30414539 |
| 44 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25992925 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.25091032 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.22745282 |
| 47 | Proteasome_Homo sapiens_hsa03050 | 1.21700706 |
| 48 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.19843365 |
| 49 | Mineral absorption_Homo sapiens_hsa04978 | 1.18541962 |
| 50 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.18366470 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.17569085 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 1.15315607 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.13234988 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 1.12006869 |
| 55 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.10845625 |
| 56 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.10425909 |
| 57 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09378361 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.08423657 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 1.07049708 |
| 60 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.06565419 |
| 61 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.06384811 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06211605 |
| 63 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.06013655 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.05924151 |
| 65 | Malaria_Homo sapiens_hsa05144 | 1.04653187 |
| 66 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.03989681 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.03134567 |
| 68 | Mismatch repair_Homo sapiens_hsa03430 | 1.02875073 |
| 69 | Homologous recombination_Homo sapiens_hsa03440 | 1.00873104 |
| 70 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.00040127 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.99439453 |
| 72 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.99060014 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.97800672 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.97347851 |
| 75 | Hepatitis C_Homo sapiens_hsa05160 | 0.94959629 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93561367 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.93144935 |
| 78 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92996440 |
| 79 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92498057 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.92488163 |
| 81 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.92247015 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.92019922 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.88769489 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.88753699 |
| 85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.88556150 |
| 86 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.87381426 |
| 87 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86910029 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.85442279 |
| 89 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85275199 |
| 90 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.84814011 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.84648465 |
| 92 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.84186730 |
| 93 | Hepatitis B_Homo sapiens_hsa05161 | 0.84113088 |
| 94 | RNA degradation_Homo sapiens_hsa03018 | 0.84111976 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.82219837 |
| 96 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81432574 |
| 97 | ABC transporters_Homo sapiens_hsa02010 | 0.81062409 |
| 98 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80819759 |
| 99 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.80556917 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.77774456 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76633311 |
| 102 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74413356 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74179753 |
| 104 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73611738 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73270600 |
| 106 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.71557950 |
| 107 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.67961469 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.67799580 |
| 109 | Basal transcription factors_Homo sapiens_hsa03022 | 0.67569356 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.67241409 |
| 111 | Salmonella infection_Homo sapiens_hsa05132 | 0.66357700 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.65759184 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.65613745 |
| 114 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.64189482 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64164942 |
| 116 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63711386 |
| 117 | RNA polymerase_Homo sapiens_hsa03020 | 0.63266129 |
| 118 | Phagosome_Homo sapiens_hsa04145 | 0.63078913 |
| 119 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62398049 |
| 120 | Focal adhesion_Homo sapiens_hsa04510 | 0.61335676 |
| 121 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.60414280 |
| 122 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59425413 |
| 123 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.57964080 |
| 124 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57248823 |
| 125 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56634550 |
| 126 | Histidine metabolism_Homo sapiens_hsa00340 | 0.56249260 |
| 127 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55575852 |
| 128 | Endocytosis_Homo sapiens_hsa04144 | 0.55434661 |
| 129 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.55104340 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.55089798 |
| 131 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54380597 |
| 132 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53051446 |
| 133 | Sulfur relay system_Homo sapiens_hsa04122 | 0.53022337 |
| 134 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51846058 |
| 135 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.51471739 |
| 136 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.51470046 |
| 137 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51438222 |
| 138 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.50500002 |
| 139 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.50414760 |
| 140 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50409441 |
| 141 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50220008 |
| 142 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.49239936 |
| 143 | Asthma_Homo sapiens_hsa05310 | 0.48884616 |
| 144 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47603640 |
| 145 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47446424 |
| 146 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47106503 |
| 147 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46038290 |
| 148 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43704534 |
| 149 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.42015092 |
| 150 | Spliceosome_Homo sapiens_hsa03040 | 0.41178048 |
| 151 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39134082 |
| 152 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38679142 |
| 153 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.38675146 |
| 154 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.38569082 |
| 155 | Insulin resistance_Homo sapiens_hsa04931 | 0.38562404 |
| 156 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.29858051 |
| 157 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.28912441 |
| 158 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.28123152 |

